Morgan Stanley upgraded Assurant (NYSE: AIZ) from Equal-Weight to Overweight and set a price target of $285. The previous price target was $240, representing a meaningful increase in the firm’s outlook for the specialty insurance company. For more on Assurant, see the Assurant dividend report.
Why the Rating Changed
Morgan Stanley’s upgrade hinges on a strengthening growth outlook for Assurant, but the catalyst behind the conviction involves more than just top-line expansion.
Members Only
This content is for DivRank members.
Get full access to all research reports, upgrade and downgrade analysis, and dividend stock coverage.